Pulmostics began clinical trial to validate novel medical device to detect breast cancer in women NEWBURY PARK, CA, US, December 13, 2022 /EINPresswire.com/ — Pulmostics Limited is pleased to announce that, in conjunction with the prestigious CHRISTUS Muguerza...
Cardinal Health Inc. stock underperforms Tuesday when compared to competitors Shares of Cardinal Health Inc. CAH, -1.58% shed 1.58% to $78.26 Tuesday, on what proved to be an all-around great trading session. Cardinal Health, Inc. found using ticker (CAH) have now 13...
